跳至主要内容
临床试验/ITMCTR1900002750
ITMCTR1900002750招募中1 期

Efficacy and immune mechanism of QingfeiTongluo prescriptions intervention on Mycoplasma pneumoniae pneumonia in children

Tianjin Nankai Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
6 至 16(—)
性别
All

入选标准

  • 1. Patients with Mycoplasma pneumoniae pneumonia or refractory Mycoplasma pneumoniae pneumonia;
  • 2. Aged 6-16 years;
  • 3. Parents signed informed consent.

排除标准

  • 1. With severe active infection or serious heart, liver, kidney and hematopoietic system diseases, or other basic diseases.
  • 2. The withdrawal time of other clinical trial drugs is less than 4 weeks.

研究者

相似试验